p53 gene therapy‐based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|11|1651-1656

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.11, 2015-11, pp. : 1651-1656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preservation of quality of life with doxorubicin drug‐eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 7, 2015-07 ,pp. : 1167-1174

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 34, Iss. 7, 2011-06 ,pp. : 368-376

Karger

Access to resources Recommend Favorite

Chemoembolization for Unresectable Hepatocellular Carcinoma in Japan

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 135-141

Karger

Access to resources Recommend Favorite

Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 317-330

Karger

Access to resources Recommend Favorite

Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1715-1721

John Wiley & Sons Inc

Access to resources Recommend Favorite